Medical Device Regulations & Compliance
INDUSTRY PERSPECTIVES
-
The Synthetic Control Mirage: Why Your Medtech RWD Strategy Will Fail In Latin America
Regulators are actively encouraging medtech companies to use real-world data and synthetic control arms. Here's why this is currently incompatible with Latin America's fragmented RWD infrastructure, though this will change in the years ahead.
Stability studies measure how medical devices respond to environmental stresses such as temperature, humidity, light, and time. Let's take a closer look at designing and conducting a stability study.
The FDA’s implementation of AI tools marks the next step in the agency’s digital transformation efforts. Let's take a closer look at how this impacts 510(k) submissions and tips for preparing your submissions.
MRAs can save resources for regulators and drug makers by, among other things, reducing the number of inspections and waiving retesting requirements.
The U.K. MHRA’s newly released framework offers long-awaited clarity by outlining when digital mental health technologies qualify as medical devices based on their intended purpose and functional impact.
WHITE PAPERS & CASE STUDIES
-
Choosing The Right PCD Configuration For Reliable Sterility Assurance
Accurate PCD configuration ensures sterility assurance. Learn how to align validation strategies with ISO standards, optimize cycle efficiency, and select the right BI format for EO sterilization success.
Learn how to be more proactive by implementing robust PFAS testing and control strategies to safeguard patient health, protect your brand, and stay ahead of evolving regulations.
A global biopharma leader modernized its complex equipment changeover process using an innovative platform to achieve faster execution, fewer errors, and greater visibility through digitized, validatable SOPs.
A human factors strategy ensures medical products are safe, effective, and compliant by integrating user-focused design early, reducing risks, and optimizing regulatory approval processes.
Container Closure Integrity Testing (CCIT) ensures drug sterility, evolving with regulatory updates like USP <1207>. Deterministic methods are preferred over probabilistic ones to maintain product integrity.
ABOUT MEDICAL DEVICE REGULATIONS & COMPLIANCE
Medical devices, from ideation to post-launch assessment, are regulated in the United States by the U.S. Food and Drug Administration (FDA) under the Medical Device Regulation Act of 1976 and subsequent amendments to the Federal Food, Drug and Cosmetics Act of 1938.
The FDA’s medical device regulatory pathways — for premarket review, clearance, and approval — are based on three classifications, indicating the degree of regulatory control necessary to ensure a device’s safety and effectiveness. Class I devices are considered low-risk, and many are exempt from the regulatory process. Class II devices require special controls for “labeling, guidance, tracking, design, performance standards, and postmarket monitoring,” and most require premarket notification 510(k) to demonstrate substantial equivalence (having the same intended use and technological characteristics) to a legally marketed device. Class III devices usually sustain or support life, are implanted, or present a significant risk of illness or injury. Most class III devices require premarket approval (PMA), which examines a variety of factors in weighing the probable health benefits from intended use of a device versus the probable risks.
Medical device makers must adhere to Current Good Manufacturing Practice (CGMP) regulations, which FDA inspectors use to determine if a manufacturer has the facilities, skills, and equipment to produce and pack its product. In addition, the FDA requires all medical devices to carry a unique device identifier (UDI), readable by both machines and humans, to “improve patient safety, modernize device postmarket surveillance, and facilitate medical device innovation.”
Medical device makers competing in international markets must monitor and adhere to the policies of foreign regulatory bodies, which can vary greatly, depending on the nation. Further, many global regulators require manufacturers to be certified by the International Organization for Standardization (ISO). ISO 13485 compliance, confirmed through third-party (Notified Body) audits, demonstrates a medical device manufacturer’s procedures and products meet or exceed international quality standards.
Efforts are also underway to standardize international regulations to ensure the safety, effectiveness, and quality of medical devices. The International Medical Device Regulators Forum (IMDRF) — composed of regulatory agencies from Australia, Brazil, Canada, China, Europe, Japan, Russia, and the United States — is building upon previous work by the Global Harmonization Task Force on Medical Devices (GHTF) to speed this harmonization and convergence.
LATEST HEADLINES
-
Accumold Makes Pharmapack Europe Debut To Support Next-Generation Drug Delivery And Pharma Packaging1/15/2026
See how precision micro molding enables scalable, reliable drug delivery and pharmaceutical packaging designs as industry experts debut at Pharmapack Europe 2026 in Paris, January 21–22.
-
AbbVie To Buy Device Manufacturing Facility From West Pharmaceutical Services1/14/2026
The acquisition of the Tempe, Arizona facility will expand U.S.-based drug delivery device capacity and support the company’s $10 billion manufacturing investment.
-
Accumold Brings Micro Molding Precision To Photonics West 2026 As Optical Innovation Accelerates1/13/2026
Accumold, a global leader in precision micro molding, will exhibit at SPIE Photonics West 2026 (January 20-22, San Francisco, USA), the premier event for lasers, biomedical optics, optoelectronics, and technologies supporting biophotonics, quantum, and vision applications.
-
Accumold Achieves ISO 13485 Recertification, Reaffirming Commitment To Precision In Medical Micro Molding11/24/2025
Accumold secures ISO 13485 recertification, reinforcing its commitment to precision, quality, and reliability in micro molded components for demanding medical device applications worldwide.
-
Accumold To Exhibit At Medevice Silicon Valley, Showcasing Micro Molding Expertise For Cutting-Edge Medtech11/11/2025
Accumold will showcase its world-leading micro molding expertise at MEDevice Silicon Valley, Booth #1034, helping medtech innovators accelerate design, de-risk production, and achieve micron-level precision.
-
Accumold To Showcase Micro Molding Innovation At COMPAMED 202511/1/2025
Discover Accumold’s micro molding expertise at COMPAMED 2025, where ultra-precision, scalability, and DfMM capabilities showcase how next-generation medical devices are enabled through unmatched miniaturization and manufacturing reliability.
-
Discover Medbio's Medical Molding Expertise At MEDevice Silicon Valley 202510/23/2025
Visit Medbio at Booth #941, November 19–20, to explore custom injection molding and assembly solutions, supporting Class I–III devices with quality, compliance, and MedTech innovation.
-
Ensera Launches As New Brand Identity For SteriPack10/14/2025
New trading name reflects expanded expertise across design, manufacturing, assembly and packing for global pharma and medical device companies.
-
MTD Expands Metrology Capabilities To Accelerate Innovation9/29/2025
MTD Micro Molding expands its metrology capabilities with a cutting-edge optical 3D system, enabling faster, traceable, nanometer-precision measurements for complex micro medical components and tooling analysis.
-
Governor Shapiro Announces $20 Million Investment From B. Braun To Expand Medical Device Manufacturing In The Lehigh Valley, Creating 200 New Jobs9/18/2025
The project will create at least 200 new, full-time jobs over the next three years and retain 1,704 existing full-time positions. The Commonwealth is supporting the project with $1.5 million in state funding.